213 related articles for article (PubMed ID: 29068481)
1. Hypophosphatemia, Severe Bone Pain, Gait Disturbance, and Fatigue Fractures After Iron Substitution in Inflammatory Bowel Disease: A Case Report.
Bartko J; Roschger P; Zandieh S; Brehm A; Zwerina J; Klaushofer K
J Bone Miner Res; 2018 Mar; 33(3):534-539. PubMed ID: 29068481
[TBL] [Abstract][Full Text] [Related]
2. Re: Hypophosphatemia, Severe Bone Pain, Gait Disturbance, and Fatigue Fractures After Iron Substitution in Inflammatory Bowel Disease: A Case Report.
Tournis S; Michopoulos S; Makris K; Terpos E
J Bone Miner Res; 2018 Mar; 33(3):543-545. PubMed ID: 29281128
[No Abstract] [Full Text] [Related]
3. Reply: Hypophosphatemia, Severe Bone Pain, Gait Disturbance, and Fatigue Fractures After Iron Substitution in Inflammatory Bowel Disease: A Case Report.
Bartko J; Roschger P; Zandieh S; Brehm A; Zwerina J; Klaushofer K
J Bone Miner Res; 2018 Mar; 33(3):546. PubMed ID: 29314243
[No Abstract] [Full Text] [Related]
4. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
5. Iron Supplementation-Induced Phosphaturic Osteomalacia: FGF23 is the Culprit.
Urbina T; Belkhir R; Rossi G; Carbonnel F; Pavy S; Collins M; Mariette X; Seror R
J Bone Miner Res; 2018 Mar; 33(3):540-542. PubMed ID: 29281120
[No Abstract] [Full Text] [Related]
6. Musculoskeletal manifestations of osteomalacia: report of 26 cases and literature review.
Reginato AJ; Falasca GF; Pappu R; McKnight B; Agha A
Semin Arthritis Rheum; 1999 Apr; 28(5):287-304. PubMed ID: 10342386
[TBL] [Abstract][Full Text] [Related]
7. Osteomalacia as a Complication of Intravenous Iron Infusion: A Systematic Review of Case Reports.
Vilaca T; Velmurugan N; Smith C; Abrahamsen B; Eastell R
J Bone Miner Res; 2022 Jun; 37(6):1188-1199. PubMed ID: 35426179
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Induced Osteomalacia in a Patient with Crohn's Disease: A Case Report and Approach to Investigating Hypophosphatemia.
Hawke K; Croft A; Lazarus S
Case Rep Gastroenterol; 2024; 18(1):81-89. PubMed ID: 38410687
[TBL] [Abstract][Full Text] [Related]
9. Tumour-induced osteomalacia.
Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
[TBL] [Abstract][Full Text] [Related]
10. [Updates on rickets and osteomalacia: etiology and pathophysiology of osteomalacia].
Suzuki H; Takeuchi Y
Clin Calcium; 2013 Oct; 23(10):1413-9. PubMed ID: 24076638
[TBL] [Abstract][Full Text] [Related]
11. Hypophosphatemic osteomalacia induced by intravenous iron therapy: a case report.
Samões B; Silva B; Martins A; Oliveira D; Rajão Martins F; Fonseca D; Costa L; Bernardes M
Joint Bone Spine; 2023 Sep; 90(5):105586. PubMed ID: 37127260
[TBL] [Abstract][Full Text] [Related]
12. Fractures and Osteomalacia in a Patient Treated With Frequent Home Hemodialysis.
Hanudel MR; Froch L; Gales B; Jüppner H; Salusky IB
Am J Kidney Dis; 2017 Sep; 70(3):445-448. PubMed ID: 28495360
[TBL] [Abstract][Full Text] [Related]
13. Subtle changes in bone mineralization density distribution in most severely affected patients with chronic obstructive pulmonary disease.
Misof BM; Roschger P; Jorgetti V; Klaushofer K; Borba VZ; Boguszewski CL; Cohen A; Shane E; Zhou H; Dempster DW; Moreira CA
Bone; 2015 Oct; 79():1-7. PubMed ID: 26003953
[TBL] [Abstract][Full Text] [Related]
14. Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review.
Kim du H; Sung DH; Min YK
J Bone Miner Metab; 2013 Mar; 31(2):240-6. PubMed ID: 22976054
[TBL] [Abstract][Full Text] [Related]
15. Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management.
Schaefer B; Tobiasch M; Wagner S; Glodny B; Tilg H; Wolf M; Zoller H
Bone; 2022 Jan; 154():116202. PubMed ID: 34534708
[TBL] [Abstract][Full Text] [Related]
16. Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial.
Insogna KL; Rauch F; Kamenický P; Ito N; Kubota T; Nakamura A; Zhang L; Mealiffe M; San Martin J; Portale AA
J Bone Miner Res; 2019 Dec; 34(12):2183-2191. PubMed ID: 31369697
[TBL] [Abstract][Full Text] [Related]
17. Hypophosphatemia in end stage renal disease.
Tejeda A; Saffarian N; Uday K; Dave M
Nephron; 1996; 73(4):674-8. PubMed ID: 8856268
[TBL] [Abstract][Full Text] [Related]
18. Iron-induced hypophosphatemia: an emerging complication.
Zoller H; Schaefer B; Glodny B
Curr Opin Nephrol Hypertens; 2017 Jul; 26(4):266-275. PubMed ID: 28399017
[TBL] [Abstract][Full Text] [Related]
19. [Osteomalacia-Clinical aspects, diagnostics and treatment].
Tiefenbach M; Scheel M; Maier A; Gehlen M; Schwarz-Eywill M; Werner M; Siebers-Renelt U; Hammer M
Z Rheumatol; 2018 Oct; 77(8):703-718. PubMed ID: 30097703
[TBL] [Abstract][Full Text] [Related]
20. [Oncogenic osteomalacia and its symptoms: hypophosphatemia, bone pain and pathological fractures].
Kaniuka-Jakubowska S; Biernat W; Sworczak K
Postepy Hig Med Dosw (Online); 2012 Aug; 66():554-67. PubMed ID: 22922156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
